|
Medicamen Biotech Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
430.74 Cr.
|
P/BV
|
1.99
|
Book Value (Rs.)
|
159.80
|
|
52 Week High/Low (Rs.)
|
630/293
|
FV/ML
|
10/1
|
P/E(X)
|
60.60
|
|
Bookclosure
|
19/09/2025
|
EPS (Rs.)
|
5.24
|
Div Yield (%)
|
0.31
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 162.55 | 177.88 | 140.41 | 108.29 | 110.72 |
| Other Operating Revenues | 0.00 | 1.43 | 0.46 | 7.15 | 1.99 |
| Total Operating Revenues | 162.55 | 179.31 | 140.87 | 115.45 | 112.72 |
| | | | | | |
| Other Income | 6.24 | 2.33 | 2.46 | 1.72 | 0.75 |
| Total Revenue | 168.79 | 181.63 | 143.33 | 117.17 | 113.47 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 90.65 | 104.70 | 81.80 | 55.69 | 68.42 |
| Purchase Of Stock-In Trade | 0.00 | 4.84 | 0.00 | 0.00 | 0.00 |
| Operating And Direct Expenses | 0.00 | 9.41 | 13.90 | 15.10 | 9.74 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -6.03 | -16.94 | -9.71 | -3.34 | 1.04 |
| Employee Benefit Expenses | 31.87 | 30.07 | 20.44 | 14.50 | 9.00 |
| Finance Costs | 3.16 | 4.40 | 2.92 | 1.40 | 1.06 |
| Depreciation And Amortisation Expenses | 7.07 | 7.09 | 6.37 | 5.77 | 2.52 |
| Other Expenses | 32.20 | 24.99 | 10.56 | 9.94 | 5.29 |
| Total Expenses | 158.91 | 168.56 | 126.28 | 99.07 | 97.08 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 9.88 | 13.08 | 17.05 | 18.09 | 16.39 |
| | | | | | |
| Profit/Loss Before Tax | 9.88 | 13.08 | 17.05 | 18.09 | 16.39 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 3.32 | 4.22 | 3.70 | 3.98 | 4.15 |
| Deferred Tax | 0.00 | -0.64 | -1.38 | -0.78 | 0.12 |
| Total Tax Expenses | 3.32 | 3.58 | 2.32 | 3.20 | 4.26 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 6.56 | 9.49 | 14.73 | 14.90 | 12.13 |
| | | | | | |
| Profit/Loss From Continuing Operations | 6.56 | 9.49 | 14.73 | 14.90 | 12.13 |
| | | | | | |
| Profit/Loss For The Period | 6.56 | 9.49 | 14.73 | 14.90 | 12.13 |
| | | | | | |
| Minority Interest | 0.55 | 1.44 | 0.12 | 0.00 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 7.11 | 10.93 | 14.84 | 14.90 | 12.13 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 5.16 | 7.50 | 11.92 | 12.19 | 9.93 |
| Diluted EPS (Rs.) | 5.16 | 7.50 | 11.92 | 12.19 | 9.93 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.00 | 1.27 | 1.22 | 0.00 |
